How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

Michael F. Chiang

doi:10.1016/j.ophtha.2018.04.018

How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

Michael F. Chiang

Ophthalmology

Research output: Contribution to journal › Editorial › peer-review

8 Scopus citations

Original language	English (US)
Pages (from-to)	1485-1487
Number of pages	3
Journal	Ophthalmology
Volume	125
Issue number	10
DOIs	https://doi.org/10.1016/j.ophtha.2018.04.018
State	Published - Oct 2018

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2018.04.018

Cite this

@article{9ed55ccdb0b8443b94d8d985efebb87a,

title = "How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example",

author = "Chiang, {Michael F.}",

note = "Funding Information: Supported by the National Institutes of Health, Bethesda, Maryland (grant nos.: R01EY19474 and P30EY10572); the National Science Foundation, Arlington, Virginia (grant no.: SCH-1622679); and by unrestricted departmental funding from Research to Prevent Blindness, Inc., New York, New York. ",

year = "2018",

month = oct,

doi = "10.1016/j.ophtha.2018.04.018",

language = "English (US)",

volume = "125",

pages = "1485--1487",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "10",

}

TY - JOUR

T1 - How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

AU - Chiang, Michael F.

N1 - Funding Information: Supported by the National Institutes of Health, Bethesda, Maryland (grant nos.: R01EY19474 and P30EY10572); the National Science Foundation, Arlington, Virginia (grant no.: SCH-1622679); and by unrestricted departmental funding from Research to Prevent Blindness, Inc., New York, New York.

PY - 2018/10

Y1 - 2018/10

UR - http://www.scopus.com/inward/record.url?scp=85053435975&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053435975&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2018.04.018

DO - 10.1016/j.ophtha.2018.04.018

M3 - Editorial

C2 - 30243329

AN - SCOPUS:85053435975

SN - 0161-6420

VL - 125

SP - 1485

EP - 1487

JO - Ophthalmology

JF - Ophthalmology

IS - 10

ER -

How Does the Standard of Care Evolve? Anti–Vascular Endothelial Growth Factor Agents in Retinopathy of Prematurity Treatment as an Example

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this